155 related articles for article (PubMed ID: 34303023)
1. Recent advances in proteomics and its implications in pituitary endocrine disorders.
Banerjee A; Goel A; Shah A; Srivastava S
Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140700. PubMed ID: 34303023
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
Li J; Zhan X
Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
Zhan X; Desiderio DM
Mass Spectrom Rev; 2005; 24(6):783-813. PubMed ID: 15495141
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.
Zhan X; Wang X; Long Y; Desiderio DM
BMC Med Genomics; 2014 Dec; 7():69. PubMed ID: 25539738
[TBL] [Abstract][Full Text] [Related]
5. Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas.
Zhan X; Evans CO; Oyesiku NM; Desiderio DM
Pituitary; 2003; 6(4):189-202. PubMed ID: 15237930
[TBL] [Abstract][Full Text] [Related]
6. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.
Moreno CS; Evans CO; Zhan X; Okor M; Desiderio DM; Oyesiku NM
Cancer Res; 2005 Nov; 65(22):10214-22. PubMed ID: 16288009
[TBL] [Abstract][Full Text] [Related]
7. The use of mass spectrometry in a proteome-centered multiomics study of human pituitary adenomas.
Li N; Desiderio DM; Zhan X
Mass Spectrom Rev; 2022 Nov; 41(6):964-1013. PubMed ID: 34109661
[TBL] [Abstract][Full Text] [Related]
8. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of invasive non-functional pituitary adenomas using exosomal biomarkers.
Ren Y; Wang Y; Bao X; Feng M; Xing B; Lian W; Yao Y; Wang R
Clin Chim Acta; 2022 Apr; 529():25-33. PubMed ID: 35085587
[TBL] [Abstract][Full Text] [Related]
10. The identification of human pituitary adenoma-initiating cells.
Manoranjan B; Mahendram S; Almenawer SA; Venugopal C; McFarlane N; Hallett R; Vijayakumar T; Algird A; Murty NK; Sommer DD; Provias JP; Reddy K; Singh SK
Acta Neuropathol Commun; 2016 Nov; 4(1):125. PubMed ID: 27894339
[TBL] [Abstract][Full Text] [Related]
11. Proteomic and functional profiles of a follicle-stimulating hormone positive human nonfunctional pituitary adenoma.
Wang X; Guo T; Peng F; Long Y; Mu Y; Yang H; Ye N; Li X; Zhan X
Electrophoresis; 2015 Jun; 36(11-12):1289-304. PubMed ID: 25809007
[TBL] [Abstract][Full Text] [Related]
12. Untargeted Lipidomics Reveals Specific Lipid Abnormalities in Nonfunctioning Human Pituitary Adenomas.
Hu C; Zhou Y; Feng J; Zhou S; Li C; Zhao S; Shen Y; Hong L; Xuan Q; Liu X; Li Q; Wang X; Zhang Y; Xu G
J Proteome Res; 2020 Jan; 19(1):455-463. PubMed ID: 31601105
[TBL] [Abstract][Full Text] [Related]
13. Increase in folate receptor alpha expression in nonfunctional pituitary adenomas.
Ding Z; Li B; Wang Q; Miao Y; Lu X
Turk Neurosurg; 2015; 25(2):298-304. PubMed ID: 26014017
[TBL] [Abstract][Full Text] [Related]
14. Signaling pathway networks mined from human pituitary adenoma proteomics data.
Zhan X; Desiderio DM
BMC Med Genomics; 2010 Apr; 3():13. PubMed ID: 20426862
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas.
Zhang Y; Li L; Ma X; Liu C; Liu G; Bie Z; Yang Z; Liu P
Front Endocrinol (Lausanne); 2023; 14():1137648. PubMed ID: 36936141
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenoma biomarkers identified using proteomic fingerprint technology.
Zhou KY; Jin HH; Bai ZQ; Liu CB
Asian Pac J Cancer Prev; 2012; 13(8):4093-5. PubMed ID: 23098522
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas.
Akbari N; Ghorbani M; Salimi V; Alimohammadi A; Khamseh ME; Akbari H; Nourbakhsh M; Sheikhi A; Taghavi SF; Tavakoli-Yaraki M
BMC Endocr Disord; 2020 Mar; 20(1):39. PubMed ID: 32171274
[TBL] [Abstract][Full Text] [Related]
18. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
[TBL] [Abstract][Full Text] [Related]
19. Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.
Chile T; Corrêa-Giannella ML; Fortes MA; Bronstein MD; Cunha-Neto MB; Giannella-Neto D; Giorgi RR
J Endocrinol Invest; 2011 Sep; 34(8):e214-8. PubMed ID: 21270509
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.
Zhan X; Huang Y; Long Y
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29658936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
